Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Long Term Debt 2015–2022
Aptevo Therapeutics Inc. annual long term debt history from 2016 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Aptevo Therapeutics Inc. long term debt as of December 31, 2022: 4.0M, a 74.99% decrease year-over-year.
- Aptevo Therapeutics Inc. long term debt for 2022 were 4.0M, a 74.99% decrease from 2021.
- Aptevo Therapeutics Inc. long term debt for 2021 were 16.0M, a 43.23% decrease from 2020.
- Aptevo Therapeutics Inc. long term debt for 2020 were 28.2M, a 46.38% increase from 2018.
- Aptevo Therapeutics Inc. long term debt for 2018 were 19.3M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aptevo Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $4 |
| 2021 | $16 |
| 2020 | $28 |
| 2018 | $19 |
| 2017 | $16 |
| 2016 | $18 |
Aptevo Therapeutics Inc. Long Term Debt — FAQ
Aptevo Therapeutics Inc. (APVO) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's long term debt history?
The chart and table above show Aptevo Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.